Fritextsökning
Innehållstyper
-
Mingling do's and don'ts
Linkedin, Facebook, MSN and Gmail are all perfect tools for the urban businessman or woman to keep track of and stay up-to-date with contacts. "But in the end, ...
-
Sophion etablerar sig i Japan
Öppnar nytt sälj och supportkontor som ska ledas av en ledande japansk elektrofysiolog.
-
Fewer visitors but satisfied exhibitors
Biotech Forum Scanlab attracted fewer visitors than in 2008. Exhibition manager Bo Rasmussen is content, claiming that the exhibitors are very satisfied.
-
Printing sensors for biological samples
Acreo develops technologies for printed electronics. Using organic printers, Acreo can print a transistor where biological samples can be placed.
-
Swedish nanotech crosses the Atlantic
Genovis signs distribution agreement Finnzymes in US.
-
"An open mind is the key to successful meetings"
Meeting in person is irreplaceble when it comes to finding a new partner. Johan Ohlsson at Venture Valuation is happy with his meetings at Biotech Forum so far ...
-
Go ahead for leg wound study
Tripep starts a phase II-study of their wound healing joint venture project.
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
New nano professor in Denmark
The Technical University of Denmark has appointed a recognized physicist as a new professor of miniaturized sensors.
-
First ever study of human stem cell treatment
The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
Swiss allergy therapy convinces
Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.
-
Steven Burrill vill starta svensk fond
Investeraren och analytikern Steven Burrill var nyligen i Sverige för besluta om han ska starta en svensk eller nordisk life science-fond. - Det finns mycket st...
-
Positive combined cancer therapy
Topotarget announces positive data with new treatment against colorectal cancer.
-
Collaboration brings next generation drugs
Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.
-
Test if you carry the fat virus
In a soon future there may be a quick and simple test that could show if you are infected with Ad-36, a human adenovirus that can make you over-weight.
-
Biotech goes white and bright
White biotech could become Denmark's next blossoming business area.
-
Diagnostics for personalized medicine
Per Matsson from Phadia anticipates changes in the standards for health care. Accordiing to him, expensive new drugs will create a market for more extensive diagnostics.
-
Två steg framåt för Bioinvent
Bioinvent och partnern Trombogneics har avslutat fas I studien av cancersubstansen TB-403. Resultaten visar att substansen tolereras väl och endast ger ett fåta...
-
Focusing on Medicon Valley
Copenhagen Capacity and Invest in Skåne are hosting a seminar to promote the geographical area known as Medicon Valley. Some of the 350 life science companies f...
-
Mingling types - who to aim for and who to avoid:
Read about different mingling types - who are you?
-
Xbrane förbereder sig för börsen
Genom att listas på Nasdaq får bolaget tillgång till en bra kapitalplattform och ökad synlighet gentemot potentiella aktieägare, säger Martin Åmark, vd för Xbra...
-
Pfizer lays a chunky bid on Wyeth
The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at app...
BREAKING